Ascendis Pharma A/S Finance Income
Ascendis Pharma A/S (ASND) reported Finance Income of EUR 114.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Income Statement › Other Income
ifrs-full:FinanceIncome · last filed 2026-02-11
- Ascendis Pharma A/S finance income for the quarter ending 2025-12-31 was 24.05M EUR.
- Ascendis Pharma A/S finance income for the quarter ending 2025-09-30 was 6.04M EUR, a 78.66% decline year-over-year.
- Ascendis Pharma A/S finance income for the quarter ending 2025-06-30 was 55.06M EUR, a 12.25% increase year-over-year.
- Ascendis Pharma A/S finance income for the quarter ending 2025-03-31 was 28.85M EUR, a 707.10% increase year-over-year.
| Period end | Finance Income 3 month | Finance Income 6 month | Finance Income 9 month | Finance Income 12 month |
|---|---|---|---|---|
| 2025-12-31 | 24.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 30.09M EUR derived: sum of 2 quarters · filed 2026-02-11 | 85.15M EUR derived: sum of 3 quarters · filed 2026-02-11 | 114.00M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 6.04M EUR 6-K · filed 2025-11-12 | 61.09M EUR derived: sum of 2 quarters · filed 2025-11-12 | 89.95M EUR 6-K · filed 2025-11-12 | 86.30M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 55.06M EUR 6-K · filed 2025-08-07 | 83.91M EUR 6-K · filed 2025-08-07 | 80.26M EUR derived: sum of 3 quarters · filed 2026-02-11 | 108.54M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | 28.85M EUR 6-K · filed 2025-05-01 | 25.20M EUR derived: sum of 2 quarters · filed 2026-02-11 | 53.48M EUR derived: sum of 3 quarters · filed 2026-02-11 | 102.53M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | -3.65M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 24.63M EUR derived: sum of 2 quarters · filed 2026-02-11 | 73.68M EUR derived: sum of 3 quarters · filed 2026-02-11 | 25.61M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 28.28M EUR 6-K · filed 2025-11-12 | 77.33M EUR derived: sum of 2 quarters · filed 2025-11-12 | 29.26M EUR 6-K · filed 2025-11-12 | 47.78M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 49.05M EUR 6-K · filed 2025-08-07 | 14.39M EUR 6-K · filed 2025-08-07 | 19.50M EUR derived: sum of 3 quarters · filed 2026-02-11 | 23.64M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 3.58M EUR 6-K · filed 2025-05-01 | -29.55M EUR derived: sum of 2 quarters · filed 2026-02-11 | -25.41M EUR derived: sum of 3 quarters · filed 2026-02-11 | 10.35M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -33.13M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -28.99M EUR derived: sum of 2 quarters · filed 2026-02-11 | 6.78M EUR derived: sum of 3 quarters · filed 2026-02-11 | 43.86M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 4.14M EUR 6-K · filed 2024-11-14 | 39.90M EUR derived: sum of 2 quarters · filed 2024-11-14 | 76.98M EUR 6-K · filed 2024-11-14 | 63.42M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 35.76M EUR 6-K · filed 2024-09-03 | 80.37M EUR 6-K · filed 2024-09-03 | 59.28M EUR derived: sum of 3 quarters · filed 2025-02-12 | 79.61M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 45.13M EUR 6-K · filed 2024-05-02 | 23.52M EUR derived: sum of 2 quarters · filed 2025-02-12 | 43.84M EUR derived: sum of 3 quarters · filed 2025-02-12 | 114.97M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -21.62M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | -1.29M EUR derived: sum of 2 quarters · filed 2025-02-12 | 69.84M EUR derived: sum of 3 quarters · filed 2025-02-12 | 52.18M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 20.33M EUR 6-K · filed 2023-11-07 | 91.45M EUR derived: sum of 2 quarters · filed 2023-11-07 | 73.80M EUR 6-K · filed 2023-11-07 | 119.63M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 71.13M EUR 6-K · filed 2023-09-05 | 84.17M EUR 6-K · filed 2023-09-05 | 99.30M EUR derived: sum of 3 quarters · filed 2024-02-07 | 120.62M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 13.04M EUR 6-K · filed 2023-04-27 | 28.17M EUR derived: sum of 2 quarters · filed 2024-02-07 | 49.49M EUR derived: sum of 3 quarters · filed 2024-02-07 | 49.64M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | 15.13M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 36.45M EUR derived: sum of 2 quarters · filed 2024-02-07 | 36.59M EUR derived: sum of 3 quarters · filed 2024-02-07 | 59.72M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 21.32M EUR 6-K · filed 2022-11-02 | 21.47M EUR derived: sum of 2 quarters · filed 2022-11-02 | 44.59M EUR 6-K · filed 2022-11-02 | 56.03M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 145.00K EUR 6-K · filed 2022-08-10 | 23.27M EUR 6-K · filed 2022-08-10 | 34.71M EUR derived: sum of 3 quarters · filed 2023-02-16 | 34.85M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | 34.43M EUR 6-K · filed 2022-05-11 | 34.56M EUR derived: sum of 2 quarters · filed 2023-02-16 | 34.70M EUR derived: sum of 3 quarters · filed 2023-02-16 | 34.79M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | 135.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | 271.00K EUR derived: sum of 2 quarters · filed 2023-02-16 | 357.00K EUR derived: sum of 3 quarters · filed 2023-02-16 | 1.81M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | 136.00K EUR 6-K · filed 2021-11-10 | 222.00K EUR derived: sum of 2 quarters · filed 2021-11-10 | 1.68M EUR 6-K · filed 2021-11-10 | -487.00K EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | 86.00K EUR 6-K · filed 2021-08-27 | 2.00M EUR 6-K · filed 2021-08-27 | -623.00K EUR derived: sum of 3 quarters · filed 2022-03-02 | 29.92M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | 11.77M EUR 6-K · filed 2021-05-27 | -709.00K EUR derived: sum of 2 quarters · filed 2022-03-02 | 29.84M EUR derived: sum of 3 quarters · filed 2022-03-02 | 33.20M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | -12.48M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 18.07M EUR derived: sum of 2 quarters · filed 2022-03-02 | 21.43M EUR derived: sum of 3 quarters · filed 2022-03-02 | 17.80M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | 30.55M EUR 6-K · filed 2020-11-12 | 33.91M EUR derived: sum of 2 quarters · filed 2020-11-12 | 30.29M EUR 6-K · filed 2020-11-12 | 42.71M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 3.36M EUR 6-K · filed 2020-08-27 | 4.92M EUR 6-K · filed 2020-08-27 | 12.16M EUR derived: sum of 3 quarters · filed 2021-03-10 | 16.43M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 4.62M EUR 6-K · filed 2020-05-19 | 8.80M EUR derived: sum of 2 quarters · filed 2021-03-10 | 13.06M EUR derived: sum of 3 quarters · filed 2021-03-10 | 35.64M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 4.18M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 8.44M EUR derived: sum of 2 quarters · filed 2021-03-10 | 31.02M EUR derived: sum of 3 quarters · filed 2021-03-10 | 24.71M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | 4.26M EUR 6-K · filed 2019-11-18 | 26.84M EUR derived: sum of 2 quarters · filed 2019-11-18 | 20.53M EUR 6-K · filed 2019-11-18 | 28.01M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | 22.57M EUR 6-K · filed 2019-08-28 | 16.27M EUR 6-K · filed 2019-08-28 | 23.75M EUR derived: sum of 3 quarters · filed 2020-04-03 | 23.91M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | 702.00K EUR 6-K · filed 2019-05-30 | 1.17M EUR derived: sum of 2 quarters · filed 2020-04-03 | 1.34M EUR derived: sum of 3 quarters · filed 2020-04-03 | 1.50M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | 470.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 635.00K EUR derived: sum of 2 quarters · filed 2020-04-03 | 793.00K EUR derived: sum of 3 quarters · filed 2020-04-03 | 923.00K EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 165.00K EUR 6-K · filed 2018-11-28 | 323.00K EUR derived: sum of 2 quarters · filed 2018-11-28 | 453.00K EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 158.00K EUR 6-K · filed 2018-08-29 | 288.00K EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | 130.00K EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | 7.30M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | 11.05M EUR 20-F · filed 2018-03-28 |